Measurement of Serum and Tissue Concentration of Moxalactam Using High Pressure Liquid Chromatography
- 1 January 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 3 (3) , 291-296
- https://doi.org/10.1097/00007691-198103000-00011
Abstract
We describe a sensitive high pressure liquid chromatographic (HPLC) procedure for the analysis of the new β-lactam antibiotic moxalactam. Conditions are described for either measurement of total drug concentration or the concentration of the individual isomers. The proteins in a 1.0 ml plasma sample are denatured with isopropyl alcohol which is then extracted into a chloroform reagent, leaving the drug in the aqueous phase. An aliquot is then injected into a μ-bondapak phenyl column. A similar extraction procedure was employed for tissue homogenates. Linear regression analysis and comparison of the HPLC assay with the microbiological assay gave a correlation coefficient of 0.97. Analysis of tissue samples indicated that significant concentrations of moxalactam were obtained at the site of infection.Keywords
This publication has 3 references indexed in Scilit:
- Steady-state moxalactam kinetics: Comparisons with other cephalosporinsClinical Pharmacology & Therapeutics, 1981
- Moxalactam (6059-S), a Novel 1-Oxa-β-Lactam with an Expanded Antibacterial Spectrum: Laboratory EvaluationAntimicrobial Agents and Chemotherapy, 1980
- LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1979